Challenges experienced during the COVID-19 pandemic shows the critical importance of research and action to accelerate the development and spread of transformational innovations for protecting and improving health in populations. How can we do much better at getting medications, vaccines, and related services to the people who need them safely, and efficiently?
To help advance this area of science, RAPID Alliance participants will also be automatically enrolled in the RAPID Alliance / STAR Study. This five year long, multi-stakeholder, multi-university study is being conducted to develop better answers to the following question: what factors affect the speed with which large-scale transformational innovations for improving the health of people can be developed and implemented in society?
Insights and perspectives you choose to share in the RAPID Alliance project will help contribute to the RAPID Alliance / STAR Study knowledge base to help strengthen answers to this question. As the researchers learn more, they will rapidly share the results of what is learned to help you and other participants speed up the processes of doing research and taking action to protect and improve the health and wellbeing of people you and your colleagues and organizations serve.
The RAPID Alliance / STAR Study is an IRB exempt study. No significant risks are identified with participation. Participants may unenroll at any time by leaving the RAPID Alliance or other communities connected with the study.
For more information, please visit
https://www.rapidalliance.org/about/research-disclosure.